Salvage therapy in heavily pretreated ovarian cancer with single agent pegylated liposomal doxorubicin (PLD): Preliminary results of a multicenter phase II study of the Hellenic Co-Operative Oncology Group.
Salvage therapy in heavily pretreated ovarian cancer with single agent pegylated liposomal doxorubicin (PLD): Preliminary results of a multicenter phase II study of the Hellenic Co-Operative Oncology Group.